0.58 +0.01 (1.79%)
GNBT
Stock Details
Last Trade:0.58 Change:+0.01 (1.79%) Prev Close:0.57 Open: 0.56 Days Range:0.56 – 0.58 52 Week Range: 0.08 - 1.14 Volume:1811067 P/E: N/AEPS:-0.39
View AllRecent Alerts 07/04/09
Recent Alert on 06/29/09 at 9:35am
Generex Biotechnology (GNBT) Prepares to Submit Positive Data From Study with MetControl
Generex Biotechnology (GNBT) Prepares to Submit Positive Data From Study with MetControl
Generex Biotechnology (Nasdaq: GNBT) has reviewed the positive data from its bioequivalent study with MetControl, its proprietary metformin chewing gum product study conducted in November 2008. Results of the fully compliant ICH-GCP conducted study... Read More
Recent Alert on 06/26/09 at 10:51am
Generex Biotechnology (GNBT) Seeing Upside After Positive Article on New Vaccine Technology
Generex Biotechnology (GNBT) Seeing Upside After Positive Article on New Vaccine Technology
Recent Alert on 06/26/09 at 9:43am
Generex (GNBT) Subsidiary Developed New Vaccine Technology Which Could Speed Up Flu Vaccine Availability
Generex (GNBT) Subsidiary Developed New Vaccine Technology Which Could Speed Up Flu Vaccine Availability
Recent Alert on 06/09/09 at 8:49am
Generex Biotechnology (GNBT) Announces Positive Study Data On Two Products
Generex Biotechnology (GNBT) Announces Positive Study Data On Two Products
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 05/05/08 at 8:01am
Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada
Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada
Blog Posts on 04/21/08 at 3:20am
Biotech in Review: Positive Consolidation in China Life Science Companies
Biotech in Review: Positive Consolidation in China Life Science Companies

